Steminov
Recent Finacing
Equity
Recent Raise
$12.5M
Steminov is a Nancy-based biotech that cultivates umbilical-cord Wharton’s jelly with proprietary 3D technology to produce its lead cell-therapy drug WhartSep for severe pneumonia.
Recent Finacing
Recent Raise
Steminov is a Nancy-based biotech that cultivates umbilical-cord Wharton’s jelly with proprietary 3D technology to produce its lead cell-therapy drug WhartSep for severe pneumonia.
